Core Viewpoint - Samsung Medical's stock closed at 29.28 yuan, up 2.74%, with a rolling P/E ratio of 18.53 times and a total market capitalization of 41.317 billion yuan [1] Company Summary - Samsung Medical operates in the smart power distribution and medical services sector, with main products including smart electricity products and solutions, smart distribution products and systems, and new energy products [1] - The company has been recognized as a national-level intellectual property demonstration enterprise, with its subsidiary Samsung Intelligent awarded as a national-level intellectual property advantage enterprise [1] - For the latest financial performance, Samsung Medical reported a revenue of 10.434 billion yuan for Q3 2024, a year-on-year increase of 25.14%, and a net profit of 1.816 billion yuan, up 21.91%, with a gross profit margin of 36.21% [1] Industry Summary - The average P/E ratio for the electric grid equipment industry is 37.08 times, with a median of 38.33 times, placing Samsung Medical at the 35th position within the industry [1] - The total market capitalization of the industry averages 94.31 billion yuan, with the median at 46.83 billion yuan [2]
三星医疗收盘上涨2.74%,滚动市盈率18.53倍,总市值413.17亿元